Biogen licenses phase 2 anti-tau antibody from bristol-myers squibb
admin 17th April 2017 Uncategorised 0Biogen Idec
More: Biogen licenses phase 2 anti-tau antibody from bristol-myers squibb
Source: MDlinx
Biogen Idec
More: Biogen licenses phase 2 anti-tau antibody from bristol-myers squibb
Source: MDlinx
© 1994 - 2024 B.M. Pharmaceuticals